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Abstract
Degradation is among the most important properties of biomaterial scaffolds, which are
indispensable for regenerative medicine. The currently used method relies on the measurement of
mass loss across different samples and cannot track the degradation of an individual scaffold in
situ. Here we report, for the first time, the use of multiscale photoacoustic microscopy to non-
invasively monitor the degradation of an individual scaffold. We could observe alterations to the
morphology and structure of a scaffold at high spatial resolution and deep penetration, and more
significantly, quantify the degradation of an individual scaffold as a function of time, both in vitro
and in vivo. In addition, the remodeling of vasculature inside a scaffold can be visualized
simultaneously using a dual-wavelength scanning mode in a label-free manner. This optoacoustic
method can be used to monitor the degradation of individual scaffolds, offering a new approach to
non-invasively analyze and quantify biomaterial-tissue interactions in conjunction with the
assessment of in vivo vascular parameters.
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Regenerative medicine requires the use of three-dimensional (3D) porous scaffolds, which
not only serve as structural supports but also provide controlled microenvironments for cells
to interact with.[1] The scaffolds are typically made of a biodegradable material in an effort
to alleviate the foreign body response caused by permanent implantation.[2] For most
applications, it is necessary to quantitatively know the degradation behaviors of such a
biodegradable scaffold. In spite of its importance and many years of research, it is still a
grand challenge to measure the degradation profile of a scaffold as the current method
typically relies on the measurement of mass loss across multiple samples. Besides its
invasive nature, the assay is labor-intensive and requires one to sacrifice a large number of
samples or animals. To address this issue, several imaging techniques have been recently
explored for non-invasive assessment of the degradation profile of an individual
scaffold.[3, 4] Although these studies were able to quantify overall changes to a scaffold, it
was very difficult to observe alterations to the fine structures of the scaffold due to limited
resolutions of the imaging modalities. As a result, we still need to develop a new imaging
technique with high spatial resolution as well as deep penetration depth for non-invasively
assessing the degradation behavior of a scaffold.
Photoacoustic microscopy (PAM) is a novel imaging modality that acquires volumetric data
in a non-invasive manner. It relies on photoacoustic signals generated by an optical-
absorbing species upon irradiation by a pulsed or intensity-modulated laser,[5] and can detect
both endogenous[6] and exogenous[7] contrasts at high spatial resolution and sensitivity,
together with relatively deep penetration depth. In addition, based on its absorption contrast
mechanism, PAM imaging is not affected by tissue autofluorescence commonly experienced
by fluorescence microscopy. Inspired by these attractive features of PAM, here we further
extended its capability to non-invasively monitor, both in vitro and in vivo, the degradation
of individual poly(D,L-lactide-co-glycolide) (PLGA) inverse opal scaffolds doped with a
contrast agent based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) formazan.
In this proof-of-concept study, we used a mixture (in equal mass) of two types of PLGAs
with lactide-to-glycolide ratios of 50:50 and 75:25, respectively, in order to achieve an
intermediate degradation kinetics.[8] We fabricated PLGA inverse opal scaffolds with a
uniform pore size of 180 μm.[1b, 6c, 6d, 9] Figure 1a shows a typical scanning electron
microscopy (SEM) image of a PLGA inverse opal scaffold at a tilt angle, revealing its three-
dimensionality, uniform pores, and a long-range ordered structure. The uniform and
interconnected pores of these scaffolds (shown in Figure 1a, inset) are critical to
homogeneous cell seeding and tissue ingrowth throughout the scaffold.[1b, 9c, 10] Typically, a
pristine PLGA inverse opal scaffold wetted with water is translucent white and barely
absorbs visible light (Fig. 1b). To generate contrast for PAM, the scaffold was doped with
MTT formazan, which rendered the scaffold a purple color (Fig. 1c). MTT formazan was
chosen as a contrast agent for the following reasons: i) formazan is relatively nontoxic;[11]
ii) MTT formazan crystals have strong absorption covering the spectral range of 490–700
nm (at half maximum), distinct from the absorption of hemoglobin or deoxy-hemoglobin
(Fig. 1d); iii) the addition of MTT formazan caused no alteration to the degradation behavior
of a PLGA scaffold (Fig. S1); iv) due to its strong hydrophobicity, MTT formazan could
hardly leak out from the scaffolds over the 6-week period tested (Fig. S2); and v) since MTT
formazan is a small molecule, it disperses well in the scaffold, and once released from the
degrading scaffold, the molecules can be quickly cleared away from the scaffold region, thus
potentially enabling accurate quantification.
The scaffolds doped with MTT formazan were then subjected to PAM imaging. In order to
demonstrate the capability of PAM to monitor the morphological changes of the scaffolds,
we examined the degradation of the PLGA inverse opal scaffolds under two different
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conditions: in plain phosphate buffered saline (PBS), and in PBS supplemented with 0.025
wt.% lipase (in vivo mimicry). Lipase was chosen because it is secreted in the body naturally
upon implantation of foreign bodies,[12] and is able to expedite the degradation of PLGA so
that a prominent contrast between the two groups can be easily observed.
Using an optical-resolution PAM (OR-PAM), which had a lateral resolution of
approximately 5 μm and a penetration depth of around 1 mm in highly scattering soft
tissues,[13] we could efficiently follow changes to the fine structure of a scaffold during its
degradation. Figure 2 shows coronal PAM projection images of a scaffold, which are color-
coded by depth of maximum from blue (surface) to red (bottom). From these images, we
could not only clearly observe the uniform pores on the surface of a scaffold, but even the
uniform windows connecting to the pores underneath (Fig. S3). The scaffold in plain PBS
only showed minor changes to the structures during the 6-week period, mainly caused by
shrinkage (Fig. 2, a–d). By contrast, the addition of lipase induced remarkably accelerated
degradation of the scaffold (Fig. 2, e–h; and i–l, magnified views). The reduction in the
overall size of the scaffold became apparent at week 2. The scaffold was largely disrupted at
week 4, with large holes appearing in the bulk of the scaffold, and the scaffold had almost
completely degraded by week 6.
PAM could also be used to quantitatively analyze the degradation of a scaffold in addition to
resolving its structural changes. To demonstrate this capability, we used an acoustic-
resolution PAM (AR-PAM; central frequency of ultrasonic transducer: 50 MHz) with a
penetration depth of around 3 mm in soft tissues and a lateral resolution of approximately 45
μm.[14] In this case, the inverse opal scaffold was monitored by AR-PAM for up to 6 weeks
at a wavelength of 638 nm (Fig. 3, a and b). It is worthy of mentioning that, at a lateral
resolution of 45 μm, the porous structure of an inverse opal scaffold was still discernible by
AR-PAM (Fig. S4). By using the PAM volumetric data, we were able to quantify the
degradation of the scaffolds (by mass) over time: the scaffolds in plain PBS had degraded
about 40% by week 6, and lipase had induced about 90% degradation for the scaffolds
during the same period of time (Fig. 3c). The quantification results obtained using PAM data
correlated well with those measured from similar scaffolds using the conventional invasive
mass loss assay (Fig. 3d).
More significantly, besides in vitro analyses, PAM could be used to track the degradation of
a scaffold in vivo. In a typical study, the PLGA inverse opal scaffolds doped with MTT
formazan were implanted in a mouse ear model,[6c] and monitored using dual wavelength
AR-PAM. Figure 4, a–d, shows coronal PAM maximum amplitude projection (MAP)
images of the same scaffold in the mouse ear at weeks 0, 1, 3, and 6 post implantation,
respectively, at a wavelength of 638 nm. We could clearly observe structural changes to the
scaffold without interference from blood vessels thanks to the limited optical absorption of
hemoglobin at the chosen wavelength. The diameter of the scaffold decreased from about 5
mm to 2.5 mm over a period of 6 weeks, together with a decrease in photoacoustic
amplitude. Using the PAM volumetric data, it was estimated that the scaffolds had degraded
about 90% by week 6 (Fig. 4e), very similar to the results obtained from the invasive mass
loss assay (about 94%, Fig. 4e). By switching to a wavelength of 578 nm, we could then
acquire images of both the scaffold and the vasculature because hemoglobin also has strong
absorption at this wavelength. After subtracting the signals from the scaffold, we were able
to look at the single component of blood vessels with minimum interference from the
scaffold (Fig. S5). Figure 4, f–i and Movies S1–S4, show co-registered 3D depictions of
blood vessels (in red) and the scaffold (in green) at weeks 0, 1, 3, and 6 post implantation.
The degradation of the scaffold and the remodeling of blood vessels within the mouse ear
could be identified at the same time. Figure 4, j–m, shows the corresponding B-scan (z
direction from the surface of the skin) images at the positions indicated by the dotted lines in
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Figure 4, f–i, respectively. The thickness of the scaffold decreased from about 1.5 mm at
week 0 to 0.8 mm at week 6, and some blood vessels were observed to develop into the void
space of the scaffold. Moreover, the area of the blood vessels was quantifiable,[6c] and
functional PAM could also be used to obtain other important parameters of the vasculature
such as blood flow velocity,[15] oxygen saturation,[16] partial pressure,[16b] and
metabolism.[17]
It should be pointed out that some photoacoustic signals were also observed from regions
outside the scaffold within the first week of implantation (Fig. 4a), which could be attributed
to small pieces of the scaffold that came off during the surgical process. These pieces
gradually disappeared or were reduced in size in the course of degradation (Fig. 4, a–d,
arrowheads). Across different time points, some of these small pieces could experience
changes in position and orientation relative to the main scaffold due to the activity of the
mouse. Interestingly, while the native vessels should not generate any intense photoacoustic
signals at a wavelength of 638 nm, a few vessels were observed in the PAM image at weeks
0 through 6 (Fig. 4, a–d). We believe that this phenomenon was likely related to the
clearance, potentially via the lymphatic system, of MTT formazan released from the scaffold
itself or the broken pieces as they were undergoing degradation. However, further studies
are needed to clarify this issue.
Finally, we demonstrated the capability of PAM to analyze the degradation of an individual
scaffold implanted subcutaneously at the dorsal site of a mouse. Unlike the ear model where
the thickness of the skin was limited to only about 200 μm, the skins around the site of
dorsal implantation had an average thickness of 1–1.5 mm. Accordingly, we changed to a
different ultrasonic transducer (central frequency: 20 MHz) for the AR-PAM system to
increase its penetration depth to the sub-centimeter scale with a reduced lateral resolution to
approximately 80 μm. As shown in Figure S6a, at such an implantation depth, PAM could
easily image the entire scaffold. We then overlaid layers of chicken breasts onto the mouse
skin at the site of implantation. Interestingly, the entire scaffold was also clearly visible after
we had added one layer of chicken breast (3 mm, Figure S6b); when a second layer was
added (6 mm in total), we were still able to observe the surface region of the scaffold with
discernible porous structure. Taking consideration of the thickness of the mouse skin, we
believe that our PAM system could resolve the structure of an entire scaffold embedded in
soft tissues as deep as around 5 mm at a reasonable lateral resolution. Such a penetration
depth could be further improved by increasing the absorption contrast of the scaffold or the
laser intensity. In addition, the degradation of the scaffold over time could still be monitored
as well. In this particular demonstration, the scaffold shrunk both in diameter and thickness
over time during the first 4 weeks post implantation, and by week 6, it had completely
degraded (Fig. S7).
In summary, we have successfully demonstrated the capability to use multiscale PAM to
non-invasively track the degradation of individual biomaterial scaffolds both in vitro and in
vivo. PAM (or photoacoustic tomography, PAT) can achieve much greater penetration
depths than pure optical imaging modalities, typically on the scale of a few hundred
micrometers to a few centimeters.[18] While such a penetration depth may suffice the needs
for small laboratory animals or near surface regions, assessment of implants at deep depths
in large animals or human objects using PAM might still be difficult. In addition, bony or
air-filled tissues cannot be effectively imaged using PAM. Despite these two major
limitations, we still consider our technique to be a great tool that may eventually become an
enabling procedure in analyzing biomaterial-tissue interactions in conjunction with the
assessment of other in vivo vascular parameters in a completely non-invasive manner.
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Figure 1.
a) A representative SEM image showing a PLGA inverse opal scaffold with uniform pores
and a long-range ordered structure. The inset shows a magnified view of a pore on the
surface, revealing the uniform windows connecting to the pores underneath. Scale bar: 100
μm. b, c) Optical micrographs showing (b) a pristine PLGA inverse opal scaffold and (c) a
PLGA inverse opal scaffold after doping with MTT formazan to render it purple in color. d)
UV-vis extinction spectra of hemoglobin, deoxy-hemoglobin, and MTT formazan crystals.
Formazan has an absorption peak at approximately 650 nm, while blood does not show
strong absorption at >600 nm.
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Figure 2.
a–h) Coronal OR-PAM projection images showing the degradation of a PLGA inverse opal
scaffold immersed in (a–d) plain PBS and (e–h) PBS containing 0.025 wt.% lipase at 37 °C
for a period up to 6 weeks. Scale bar: 2 mm. i–l) Magnified views showing the top-left
corner of the images in (e–h), respectively. While the scaffold in PBS did not undergo
obvious structural alterations up to week 6, the scaffold showed remarkable changes over
time in the presence of lipase. Scale bar: 1 mm. The images are color-coded by depth of
maximum.
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Figure 3.
a, b) AR-PAM MAP coronal (left row) and sagittal images (right row) showing the
degradation of a PLGA inverse opal scaffold immersed in (a) plain PBS and (b) PBS
containing 0.025 wt.% lipase at 37 °C for a period of up to 6 weeks. c) Quantification of
degradation using PAM volumetric data. By week 6, the scaffolds in plain PBS only
degraded about 40% while the scaffolds in lipase-containing PBS had almost degraded
completely. d) Quantification of the degradation in PBS in the absence and presence of
lipase, respectively, using the conventional invasive mass loss assay, which showed profiles
similar to what were obtained from PAM. MAP stands for “maximum amplitude
projection”.
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Figure 4.
a–d) AR-PAM coronal MAP images taken from the same PLGA inverse opal scaffold
implanted in the ear of a nude mouse at weeks 0, 1, 3, and 6 post implantation, respectively.
The arrowheads indicate small pieces of the scaffold that likely came off during the surgery,
and their slight changes in position and orientation relative to the main scaffold at different
time points could be attributed to the activity of the mouse. Scale bars: 2 mm. e)
Comparison of the degradation profiles of scaffolds as a function of time obtained from the
same scaffold using PAM and from different scaffolds using the conventional invasive mass
loss assay. f–i) Co-registered 3D reconstruction images showing both the degradation of a
scaffold (the same piece) and the remodeling of vasculature simultaneously. Scale bars: 2
mm. j–m) Co-registered B-scan images at the dotted planes as indicated in (f–i),
respectively. The blood vessels observed at week 0 were mainly located on the top surface
of the scaffold. Scale bars: 1 mm. MAP stands for “maximum amplitude projection”.
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